-
Change Your Brain, Change Your Body
-
FREE Newsletter!
Receive 10% off of your next order from our online store!
We respect your privacy, we do not sell or distribute your personal information
-
Changing Lives
- We can not thank the staff enough!! You have saved our little boy. We are having the most wonderful time getting to know our "true son." Thank You and God Bless
The predominant cause of memory loss is a family of diseases called Alzheimer’s Disease and related disorders (ADRD) which includes but is not limited to Alzheimer ‘ s Disease, vascular dementia, Parkinson ‘ s Disease, and Frontal Lobe dementia. In addition to ADRD, many other conditions cause memory loss. The tables that follow list the major causes of memory loss, the appropriate treatment, and the result of treatment.
Alzheimer’s Disease and Related Disorders
|
Disease |
Treatment |
Result of Treatment |
|
Alzheimer ‘ s Disease |
Cholinesterase inhibitor and glutamate modulation |
Stabilization and sometimes improvement |
|
Parkinson ‘ s Disease |
Dopaminergic stimulation |
Stabilization and sometimes improvement |
|
Frontal Lobe Dementia |
No established treatment |
Not applicable |
|
Vascular Disease |
Treat illness and risk factors |
Stabilization and sometimes improvement |
Other Causes of Memory Loss and Dementia
|
Disease |
Treatment |
Result of Treatment |
|
Anxiety |
Anti-anxiety supplements or meds |
Improvement |
|
ADHD |
Stimulant supplements or meds |
Improvement |
|
Depression |
Antidepressant supplement or meds |
Improvement |
|
Thyroid disease |
Thyroid hormone |
Improvement |
|
Diabetes |
Diet, exercise, meds |
Improvement |
|
Metabolic problems |
Diagnose etiology and treat |
Improvement |
|
Alcohol dependence |
Alcohol cessation |
Improvement |
|
Drug abuse |
Drug cessation |
Improvement |
|
Vit. B-12 deficiency |
Vit. B-12 replacement |
Improvement |
|
Vit. D deficiency |
Vit. D replacement |
Improvement |
|
Brain infections |
IV antibiotics |
Improvement |
|
Medications |
Adjust medication |
Improvement |
|
Fatigue |
Diagnose cause and treat |
Frequent improvement |
|
Head injury |
Cognitive therapy and medication |
Frequent improvement |
|
Hydrocephalus |
Shunt |
Frequent improvement |
|
Cancer |
Diagnose and treat |
Frequent improvement |
|
Cancer chemotherapy |
Brain healthy program |
Frequent improvement |
- Types of Memory
- Memory Problems
- Understanding and Treating Memory Loss
- Medical Tests to Consider to Evaluate Memory Problems
- Supplements That May Be Helpful to Enhance Memory
March 7, 2009 ““ 9:12 am
The bacteria Helibacter pylori has been found to be one of the main cause of ulcers. In an important new study, just published in the Journal of Neurology, it was also found to also be involved with Alzheimer’s disease. If this finding holds up, everyone with memory issues should be screened for the bacteria and treated for it.
Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer’s disease
Abstract Infectious agents have been proposed as potential causes of Alzheimer’s disease (AD). Recently, we documented a high prevalence of Helicobacter pylori (Hp) infection in patients with AD.
We aim to access the effect of Hp eradication on the AD cognitive (MMSE: Mini Mental State Examination and CAMCOG: Cambridge Cognitive Examination for the Elderly) and functional (FRSSD: Functional Rating Scale for Symptoms of Dementia) status parameters.
In the first part of the study, a total of 50 consecutive patients with AD and 30 age-matched anaemic controls underwent an upper gastrointestinal endoscopy, and gastric mucosal biopsies were obtained to detect the presence of Hp infection by histologic analysis and rapid urease test.
Serum anti-Hp-specific IgG level was analysed by enzyme-linked immunosorbent assay. In the second part, Hp-positive AD patients received a triple eradication regimen (omeprazole, clarithromycin and amoxicillin), and all patients were followed up for 2 years, while under the same treatment with cholinesterase inhibitors.
Hp was detected in 88% of AD patients and in 46.7% of controls (P < 0.001). Hp eradication was successful in 84.8% of treated patients.
At the 2-year clinical endpoint, cognitive and functional status parameters improved in the subgroup of patients where Hp eradication was successful (P < 0.001 and P = 0.049 for MMSE and CAMCOG, respectively; P < 0.001 for FRSSD), but not in the other patients.
Hp eradication may positively influence AD manifestations, suggesting a possible common link between Hp and AD.
http://www.springerlink.com/content/83147756538×7031/
Share this Article
Found this article useful or interesting? Share it with others!

